Why Neil Woodford Has Sold Smith & Nephew Plc But Bought More Centrica Plc And SSE Plc

Dave Sullivan reviews some of the recent contrarian trades made by Neil Woodford’s equity income fund: Smith & Nephew plc (LON: SN), Centrica plc (LON: CNA) and SSE plc (LON: SSE).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In the recently released February Fund round-up of Neil Woodford’s equity income fund, there were a few transactions that stood out to me as being rather contrarian.

Selling Out Of The Takeover Target

The fund has now disposed of its entire position in Smith & Nephew (LSE: SN).  Mr Woodford acknowledged that a bid for the company may well lead to a considerable appreciation in the share price.  However, with the share price at an all-time high, he felt that there were better opportunities elsewhere.  It is true that the company trades on a fairly lofty forward multiple of around 19 times earnings and expects to yield less than 2%.  It is also possible that the deal was sealed when Stryker, the US healthcare company, announced a $2 billion share buyback last week, finally quashing hopes that a bid was about to be announced.

Topping Up On The Unloved

In contrast, Mr Woodford seems to have seen an opportunity following the share price weakness of both Centrica (LSE: CNA) and SSE (LSE: SSE).

Centrica was the largest detractor to the funds performance in February, after the company cut its dividend with its full-year results.  Mr Woodford didn’t feel that the dividend cut was necessary but this may have simply be down to the new chief executive, Ian Conn, taking the opportunity to get any bad news out of the way early in his tenure rather than risk a credit downgrade.  It is fair to say that a dividend cut was already largely reflected in the share price. Centrica was hit by a combination of factors recently:

  • US and UK weather conditions;
  • The oil price collapse;
  • Political and regulatory pressure.

However, he felt that these issues will abate and its long-term valuation attractions will become much more apparent.  He topped up on both Centrica and SSE, which was weak in sympathy.

Whilst we will have to wait until May for SSE’s full-year results and its final dividend, it did release a third-quarter trading update on 26th January.  It stated that:

  • SSE still expects to report an increase in the full-year dividend for 2014/15 that will at least be equal to RPI inflation;
  • Confirms that SSE is targeting an increase in the full-year dividend for 2015/16 of at least RPI inflation, with annual increases thereafter of at least RPI inflation also being targeted.

Where Does That Leave Us Investors?

With no dividend cut, SSE still yields over 6% but with RPI currently at just over 1% I wouldn’t expect outsized increases, either.  Whilst Centrica has bitten the bullet by re-basing its dividend, this will assist in reducing its debt and maintain capital expenditure — in the long run, it may be seen as a smart move… as may Neil Woodford’s top-ups.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Dave Sullivan has no position in any shares mentioned. The Motley Fool UK has recommended Centrica. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »